FT, Author at Association for Prescription Psychedelics

Association for Prescription Psychedelics Congressional Information Request Response

Organization makes the case for advancing prescription psychedelic medicine to the Congressional PATH Caucus. FOR IMMEDIATE RELEASE February 28, 2025 CONTACT contact@psychedelicsrx.org WASHINGTON, D.C. – The Association for Prescription Psychedelics (APP) responded to a Request for Information (RFI) by the Congressional Psychedelics Advancing Therapies (PATH) Caucus on the implementation of programs and policies that expand […]

Press ReleaseFebruary 28, 2025March 10, 2025 By FT

We’re Launching a New Organization to Accelerate the Development of Safe and Effective Prescription Psychedelic Medicines. Here’s Why.

By Jon Kostas This November, voters resoundingly rejected several initiatives to expand state-led psychedelics legalization and decriminalization efforts. Safe, effective, and professionally administered psychedelic medicines have transformative potential to help treat patients with generalized anxiety disorder, major depressive disorder, post-traumatic stress disorder (PTSD), substance abuse disorders, and many other adverse health conditions. But the election […]